Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Crespo

Showing results (161-170 of 365) with videos related to

Pageof 37
Sort By:
International Journal of Molecular Sciences|July 14, 2023
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is KeyMarta Alonso-Peña, Maria Del Barrio, Ana Peleteiro-Vigil, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 13, 2023
High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver diseaseAitor Odriozola, Ángela Puente, Antonio Cuadrado, et al.
Revista Espanola De Enfermedades Digestivas|December 28, 2019
Principles for implementing a population screening strategy for hepatitis C in SpainJoaquín Cabezas, Federico García, José Luis Calleja Panero, et al.
Advances in Laboratory Medicine|June 26, 2023
Measurement and clinical usefulness of bilirubin in liver diseaseArmando Raúl Guerra Ruiz, Javier Crespo, Rosa Maria López Martínez, et al.
JMIR Medical Education|June 8, 2026
AI Integration in Spanish Undergraduate Medical Education: National Cross-Sectional StudyAna Enériz Janeiro, Karina Pitombeira Pereira, Julio Mayol, et al.
Biomedicines|January 21, 2022
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to TargetsAlvaro Santos-Laso, María Gutiérrez-Larrañaga, Marta Alonso-Peña, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis CEva Martínez-Bauer, Javier Crespo, Manuel Romero-Gómez, et al.
Revista Espanola De Enfermedades Digestivas|March 18, 2017
Multicenter study on the safety of bariatric endoscopyEduardo Espinet Coll, Javier Nebreda Durán, Gontrand López-Nava Breviere, et al.
International Journal of Cardiology|June 25, 2018
Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosisGemma Vilahur, Laura Casaní, Esther Peña, et al.
Gastroenterologia Y Hepatologia|October 15, 2013
Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in SpainJuan Turnes, Manuel Romero-Gómez, Ramón Planas, et al.
Pageof 37

Showing results (161-170 of 365) with videos related to

Sort By:
Pageof 37
International Journal of Molecular Sciences|July 14, 2023
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is KeyMarta Alonso-Peña, Maria Del Barrio, Ana Peleteiro-Vigil, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 13, 2023
High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver diseaseAitor Odriozola, Ángela Puente, Antonio Cuadrado, et al.
Revista Espanola De Enfermedades Digestivas|December 28, 2019
Principles for implementing a population screening strategy for hepatitis C in SpainJoaquín Cabezas, Federico García, José Luis Calleja Panero, et al.
Advances in Laboratory Medicine|June 26, 2023
Measurement and clinical usefulness of bilirubin in liver diseaseArmando Raúl Guerra Ruiz, Javier Crespo, Rosa Maria López Martínez, et al.
JMIR Medical Education|June 8, 2026
AI Integration in Spanish Undergraduate Medical Education: National Cross-Sectional StudyAna Enériz Janeiro, Karina Pitombeira Pereira, Julio Mayol, et al.
Biomedicines|January 21, 2022
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to TargetsAlvaro Santos-Laso, María Gutiérrez-Larrañaga, Marta Alonso-Peña, et al.
Hepatology (Baltimore, Md.)|December 24, 2005
Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis CEva Martínez-Bauer, Javier Crespo, Manuel Romero-Gómez, et al.
Revista Espanola De Enfermedades Digestivas|March 18, 2017
Multicenter study on the safety of bariatric endoscopyEduardo Espinet Coll, Javier Nebreda Durán, Gontrand López-Nava Breviere, et al.
International Journal of Cardiology|June 25, 2018
Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosisGemma Vilahur, Laura Casaní, Esther Peña, et al.
Gastroenterologia Y Hepatologia|October 15, 2013
Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in SpainJuan Turnes, Manuel Romero-Gómez, Ramón Planas, et al.
Pageof 37